title: [Rifamycins, vancomycin and fosfomycin. A privileged use: Staphylococci resistant to methicillin].
authors.forename: B
authors.initials: B
authors.lastname: Régnier
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D005578:Fosfomycin / Q000494:pharmacology*; D008712:Methicillin / Q000494:pharmacology; D010403:Penicillin Resistance; D012294:Rifamycins / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D012294:Rifamycins; D005578:Fosfomycin; D014640:Vancomycin; D008712:Methicillin
vernacular_title: Rifamycines, vancomycine et fosfomycine. Une utilisation privilégiée: les staphylocoques résistant à la méticilline.